Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_assertion type Assertion NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_head.
- NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_assertion wasGeneratedBy ECO_0000203 NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_provenance.
- NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_assertion wasDerivedFrom befree-2016 NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_provenance.
- NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_assertion SIO_000772 16457150 NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_provenance.
- NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_assertion evidence source_evidence_literature NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_provenance.
- NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_assertion description "[BRCA1-associated breast cancers (BABC) were significantly less likely to be diagnosed at stage I than breast cancers in women without mutations (12.5% vs 51%; P = 0.045), more likely to have a high proliferation rate (100% vs 24%, P < 0.001), and more likely to be histological grade 3 (100% vs 14%, P < 0.001), estrogen and progesterone receptor negative (87.5% vs 13%, P < 0.001; 75% vs 23%, P = 0.004), and p53 positive (87.5% vs 30%, P = 0.023).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534454.RA7vaY5IrC2N_HPfEc3yni224L-tzmgpwNfC7GPXTkPFI130_provenance.